Status:
UNKNOWN
Association Between Labor Induction and Birth Weight in Cases of Fetal Macrosomia: The MACROMODA Cohort Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Birth Weight
Macrosomia, Fetal
Eligibility:
FEMALE
12-50 years
Brief Summary
The rising prevalence fof fetal macrosomia represents a significant challenge in obstetrics, affecting both maternal and neonatal outcomes. Such challenges include complications like perineal tears an...
Eligibility Criteria
Inclusion
- Full-term deliveries (≥ 37 weeks of gestation)
- Singleton
- Birth weight \> 4000g
- Complete medical records available for analysis
Exclusion
- Delivery \< 37 weeks
- Uterus \> bi-scarred
- Presentation of the headquarters
- Maternal or fetal pathology modifying the route/time of delivery (pre-eclampsia, fetal heart rate abnormalities, cholestasis, chorioamnionitis, metrorrhagia, covering placenta, etc.)
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
4500 Patients enrolled
Trial Details
Trial ID
NCT06198881
Start Date
October 1 2023
End Date
January 1 2024
Last Update
January 10 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme-Mère-Enfant
Bron, France, 69500
2
Croix Rousse Hospital
Lyon, France, 69004
3
Hôpital Lyon Sud
Pierre-Bénite, France, 69495